Small molecule BAG1L inhibitors for the treatment of androgen receptor-dependent prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Karlsruhe, Karlsruher Institut für Technologie (KIT), Dissertation, 2020
- Event
-
Veröffentlichung
- (where)
-
Karlsruhe
- (who)
-
KIT-Bibliothek
- (when)
-
2022
- Creator
- Contributor
-
Cato, A.
- DOI
-
10.5445/IR/1000129434
- URN
-
urn:nbn:de:101:1-2022080305010311978994
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:43 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kuznik, Nane
- Cato, A.
- KIT-Bibliothek
Time of origin
- 2022
Other Objects (12)
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Lestaurtinib inhibits histone phosphorylation and androgen-dependent gene expression in prostate cancer cells
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
IKappaB-kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines
Androgen-regulation of sepsis response : beneficial role of androgen receptor antagonists
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Lestaurtinib inhibits histone phosphorylation and androgen-dependent gene expression in prostate cancer cells
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
IKappaB-kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines
Androgen-regulation of sepsis response : beneficial role of androgen receptor antagonists
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Lestaurtinib inhibits histone phosphorylation and androgen-dependent gene expression in prostate cancer cells
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
IKappaB-kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines